(EMAILWIRE.COM, May 11, 2017 ) Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain are some of the major symptoms of hepatitis B. Having a chronic HBV may lead to serious implications like liver cancer and liver failure.

Keeping the threat in mind, many governments in the European countries and the US have made it mandatory for the people to go through the screening and proper monitoring since hepatitis B takes time to develop and is not easily recognizable. There are some curative therapies available but they are not very efficient. It is expected that many innovative therapies which have shown positive results in trials will occupy the market in the coming years. Many companies have products related to hepatitis B in their pipeline.

For more information about this report: http://www.reportsweb.com/global-hepatitis-b-virus-hbv-market-10-year-demand-forecast-2016-2025

The key factors driving the growth of hepatitis B market are increase in liver cancer and cirrhosis deaths, increasing ageing population, increasing healthcare expenditure and urbanization leading to better monitoring and screening procedures. Some of the noteworthy trends and developments of this industry are new HBV treatments in development, government initiative and public awareness, collaboration, innovation and research, preference for biomarker based tests. However, the expansion of hepatitis B market is hindered by rigid competition, management challenges, lack of diagnostic facilities and high cost of medical care and legal regulations.

The report "Global Hepatitis B Virus (HBV) Market - 10 Year Demand Forecast (2016-2025) " provides an in-depth analysis of the global market along with markets of the US and Europe. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises large players such as Arrowhead, Arbutus, Gilead and Johnson & Johnson. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001532600/sample

Table of Contents

1. Market Overview
2. Global HBV Market Analysis
3. Regional Market Analysis
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles
6.1 Arrowhead Pharmaceuticals
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Arbutus Pharma
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Gilead
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Johnson & Johnson
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

Inquire for Report at http://www.reportsweb.com/inquiry&RW0001532600/buying

Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results